BERLIN--(BUSINESS WIRE)-- The European Foundation for the Study of Diabetes (EFSD) today announced that Dr Ivonne Loeffler, University Hospital, Jena, Germany is the recipient of this year’s award for the ‘EFSD/Janssen Programme for the Study of the Role of the Kidney in Diabetes’. Dr Loeffler will be looking into the role of collagen type Vlll in epithelial-mesenchymal transition in diabetic nephropathy, advancing knowledge in a therapy area which affects an estimated 329 million people worldwide.
The award programme, initiated in 2010, is a joint partnership between EFSD and Janssen and offers joint funding of up to €300,000 per year. Within this up to €100,000 is available for basic research projects and €200,000 for clinical research projects, with a view to improving disease management.
Also announced today, four leading young researchers have been awarded EFSD/Janssen Research Fellowships in conjunction with the European Association for the Study of Diabetes (EASD) Rising Star Symposium in recognition of their innovative work in diabetes research. Amélie Bonnefond, Lille Pasteur Institute, France; Josefine Beulens, Utrecht University, The Netherlands; Laura Herrero, University of Barcelona, Spain and Henrike Sell, German Diabetes Center, Duesseldorf, Germany will present an overview of their past and current research activities at the EASD Rising Star Symposium and will each receive further funding of €30,000 to continue their work through the EFSD/Janssen Research Fellowships.
“Diabetes is a global concern and the social and economic impact of this disease is increasing as the incidence and prevalence of diabetes continues to grow. Through our partnership with Janssen, we are pleased to support further research into the role of the kidney in diabetes and also to recognise and support the emerging researchers who have valuable contributions to make to expand our knowledge and understanding of diabetes” said Prof Andrew Boulton, President EFSD.
“Janssen is committed to working alongside the diabetes community and is proud to sponsor the EFSD/Janssen Programme for the Study of the Role of the Kidney in Diabetes and the EFSD/Janssen Research Fellowships during the Rising Stars Symposium at the EASD Annual Meeting. Programmes such as these stimulate and accelerate vital research that could contribute to improving management of the disease and patient care” commented Brian Woodfall, Vice President Janssen EMEA Medical Affairs.
-- ENDS --
Notes to editors
For more information about the EFSD/Janssen research programme visit: http://www.europeandiabetesfoundation.org/
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.
The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology, immunology, neuroscience, infectious disease, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop innovative products, services and healthcare solutions to help people throughout the world.
More information can be found at www.janssen-emea.com
Janssen, Public Affairs & Communications EMEA
Phone: +32 (0)14 60 7172
Phone: +44 (0)207 861 2806 / +44 (0)779 470 0151